Collaborative Efforts and Reports. The parties agree that the successful execution of the R & D Program will require the collaborative use of both parties' areas of expertise. The parties shall keep each other fully informed about the status of the portions of the R & D Program they respectively perform. Designated representatives of SIGA and WYETH-AYERST shall cooperate in the performance of the R & D Program and, subject to any confidentiality obligations to third parties, shall exchange information and materials as necessary to carry out the R & D Program, but subject to the provisions of Sections 4 and 5 hereof. Each party will attempt to accommodate any reasonable request of the other party to send or receive personnel for purposes of collaborating or exchanging information under the R & D Program. Such visits and/or access will have defined purposes and be scheduled in advance. Each party will bear its relevant travel and lodging costs.
Appears in 2 contracts
Sources: Collaborative Research and License Agreement (Siga Pharmaceuticals Inc), Collaborative Research and License Agreement (Siga Pharmaceuticals Inc)